Literature DB >> 8532839

Measurements of radiobiological effectiveness in the 85 MeV proton beam produced at the cyclotron CYCLONE of Louvain-la-Neuve, Belgium.

J Gueulette1, V Grégoire, M Octave-Prignot, A Wambersie.   

Abstract

The RBE of the 85 MeV proton beam produced at the cyclotron of Louvain-la-Neuve using 60Co gamma rays as the reference radiation was determined for survival of Chinese hamster ovary cells in vitro and for intestinal crypt regeneration in mice in vivo. Cell survival curves determined at different depths yielded, for a surviving fraction (SF) of 0.01, RBE values of 1.11 +/- 0.05 at the initial plateau of the unmodulated beam, 1.10 +/- 0.03 at the middle of a 0.5-cm spread-out Bragg peak (SOBP), 1.03 +/- 0.03 at the beginning of a 3-cm SOBP and 1.07 +/- 0.03 at the end of a 3-cm SOBP. The highest RBE values were obtained at the middle of the 0.5-cm SOBP and at the end of the 3-cm SOBP (RBE = 1.22 and 1.16, respectively, at SF = 0.5), although the variations are not statistically significant. Irradiations with 3-Gy fractions separated by an interval of 3.5 h yielded RBEs of 1.11 +/- 0.30 and 0.90 +/- 0.32 at the initial plateau and at the middle of the 0.5-cm SOBP, respectively. Irradiations of mice at the middle of the 3-cm SOBP yielded an RBE of 1.08 +/- 0.03 for 20 regenerated crypts at a proton dose of 12.3 Gy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8532839

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  8 in total

1.  RBE, reference RBE and clinical RBE: applications of these concepts in hadron therapy.

Authors:  A Wambersie
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

2.  Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: a phantom study.

Authors:  R T Flynn; D L Barbee; T R Mackie; R Jeraj
Journal:  Phys Med Biol       Date:  2007-10-01       Impact factor: 3.609

3.  Comparison of radiobiological effective depths in 65-MeV modulated proton beams.

Authors:  J T Tang; T Inoue; T Inoue; H Yamazaki; S Fukushima; N Fournier-Bidoz; M Koizumi; S Ozeki; K Hatanaka
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Relative biological effectiveness of the 60-MeV therapeutic proton beam at the Institute of Nuclear Physics (IFJ PAN) in Kraków, Poland.

Authors:  Dorota Słonina; Beata Biesaga; Jan Swakoń; Damian Kabat; Leszek Grzanka; Marta Ptaszkiewicz; Urszula Sowa
Journal:  Radiat Environ Biophys       Date:  2014-07-19       Impact factor: 1.925

5.  Protective effects of dietary antioxidants on proton total-body irradiation-mediated hematopoietic cell and animal survival.

Authors:  Chris O Wambi; Jenine K Sanzari; Carly M Sayers; Manunya Nuth; Zhaozong Zhou; James Davis; Niklas Finnberg; Joan S Lewis-Wambi; Jeffrey H Ware; Wafik S El-Deiry; Ann R Kennedy
Journal:  Radiat Res       Date:  2009-08       Impact factor: 2.841

6.  Investigating Dependencies of Relative Biological Effectiveness for Proton Therapy in Cancer Cells.

Authors:  Michelle E Howard; Chris Beltran; Sarah Anderson; Wan Chan Tseung; Jann N Sarkaria; Michael G Herman
Journal:  Int J Part Ther       Date:  2018-03-21

7.  A High-Precision Method for In Vitro Proton Irradiation.

Authors:  Michelle E Howard; Janet M Denbeigh; Emily K Debrot; Nicholas B Remmes; Michael G Herman; Chris J Beltran
Journal:  Int J Part Ther       Date:  2020-10-01

8.  Basics of particle therapy II: relative biological effectiveness.

Authors:  Jinhyun Choi; Jin Oh Kang
Journal:  Radiat Oncol J       Date:  2012-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.